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Interaction of Akt-Phosphorylated Ataxin-1
with 14-3-3 Mediates Neurodegeneration
in Spinocerebellar Ataxia Type 1
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servations raise several important questions: what fac-Summary
tors contribute to the altered protein conformation? How
exactly do misfolded proteins induce neuronal dysfunc-Spinocerebellar ataxia type 1 (SCA1) is one of several
tion and degeneration? And what factors modulate theirneurological disorders caused by a CAG repeat expan-
toxicity?sion. In SCA1, this expansion produces an abnormally
The subcellular localization of the polyglutamine pro-long polyglutamine tract in the protein ataxin-1. Mu-
tein, the ratio of the polyglutamine tract to the hosttant polyglutamine proteins accumulate in neurons,
protein, and native protein sequences flanking the CAGinducing neurodegeneration, but the mechanism un-
repeat all affect the toxicity of polyglutamine proteinsderlying this accumulation has been unclear. We have
(Zoghbi and Botas, 2002). Protein modifications such asdiscovered that the 14-3-3 protein, a multifunctional
phosphorylation may also have an effect: in Alzheimer’s
regulatory molecule, mediates the neurotoxicity of
disease (AD), for example, brain dysfunction and degen-
ataxin-1 by binding to and stabilizing ataxin-1, thereby eration are linked to the accumulation of the neurofibril-
slowing its normal degradation. The association of lary tangles that are highly enriched in the hyperphos-
ataxin-1 with 14-3-3 is regulated by Akt phosphoryla- phorylated forms of the microtubule-associated protein
tion, and in a Drosophila model of SCA1, both 14-3-3 tau (Lee et al., 2001). Enhanced phosphorylation of tau
and Akt modulate neurodegeneration. Our finding that by glycogen synthase kinase 3 (GSK3) induces fila-
phosphatidylinositol 3-kinase/Akt signaling and 14-3- mentous tau inclusions and accelerates tau-induced
3 cooperate to modulate the neurotoxicity of ataxin-1 neurodegeneration in transgenic flies (Jackson et al.,
provides insight into SCA1 pathogenesis and identifies 2002) and mice (Lucas et al., 2001). Given these findings,
potential targets for therapeutic intervention. we enquired whether protein phosphorylation might play
a role in SCA1 pathogenesis as well.
Introduction Recently, Emamian and colleagues demonstrated
that ataxin-1 is phosphorylated at serine 776 (S776) and
Spinocerebellar ataxia type 1 (SCA1) is an autosomal that substitution of this S776 residue with alanine (A776)
dominant neurodegenerative disease caused by the greatly diminishes the ability of mutant ataxin-1 to ag-
expansion of a CAG repeat that produces an abnormally gregate (Emamian et al., 2003). These results suggest
long polyglutamine tract in the ataxin-1 protein. At least that a serine at position 776 of ataxin-1 plays a role
in SCA1 pathogenesis. Because this serine is normally
phosphorylated, we speculated that S776 phosphoryla-9Correspondence: hzoghbi@bcm.tmc.edu
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Figure 1. Ataxin-1 Interacts with 14-3-3
(A) Lysates from COS1 cells transfected with FLAG-ataxin-1[82Q] (S776 or A776) or mock control were immunoprecipitated by anti-FLAG
antibodies. 14-3-3 and 14-3-3 interact specifically with ataxin-1[82Q]-S776. (hsp: heat shock proteins)
(B) Association of ataxin-1 and 14-3-3 requires S776. Lysates of COS1 cells cotransfected with FLAG-tagged ataxin-1[82Q] (S776 or A776)
or bi-cistronic HA-14-3-3 and myc-14-3-3 (pIRES-HA-14-3-3/myc-14-3-3) were immunoprecipitated by either anti-FLAG or anti-HA antibod-
ies. The lysates (input) and immunoprecipitates were analyzed by immunoblotting with anti-FLAG or mixtures of anti-HA and anti-14-3-3
antibodies.
(C) Ataxin-1 homologs from different species share a consensus 14-3-3 binding motif.
tion might modify ataxin-1 neurotoxicity by regulating lecular masses of 30 and 28 kDa coprecipitated only with
ataxin-1[82Q]-S776. The mass values of their derivedits protein-protein interactions. To test this hypothesis,
peptides matched the  and  isoforms of 14-3-3, awe sought to identify proteins that interact with ataxin-
protein family of multifunctional regulatory molecules1-S776 but not ataxin-1-A776, to identify the kinase that
(Fu et al., 2000).phosphorylate S776 in ataxin-1, and examine the effects
To verify the interaction between ataxin-1 and 14-of these factors on SCA1 pathogenesis.
3-3, we performed immunoprecipitation on lysates from
COS1 cells transfected with FLAG-tagged ataxin-1 and
Results a plasmid bi-cistronically expressing HA-tagged 14-3-
3 and myc-tagged 14-3-3 proteins (Figure 1B). Ataxin-
Ataxin-1 Interacts with 14-3-3 1[82Q]-S776 immunoprecipitated both 14-3-3 (lanes 4
To identify proteins that preferentially interact with and 5, Figure 1B) and 14-3-3 (lane 5, Figure 1B), but
ataxin-1-S776, we performed immunoprecipitation on ataxin-1[82Q]-A776 failed to pull down any of the 14-
cell lysates from COS1 cells transiently transfected with 3-3 proteins (lane 6, Figure 1B). Conversely, 14-3-3 im-
FLAG-tagged ataxin-1 containing 82 glutamines (82Q) munoprecipitated only ataxin-1[82Q]-S776 (compare
and either a serine (ataxin-1[82Q]-S776) or an alanine lanes 8 and 9, Figure 1B). Complex formation between
(ataxin-1[82Q]-A776) at position 776. SDS-PAGE analy- ataxin-1 and 14-3-3 in vivo thus requires the serine resi-
sis revealed several polypeptides that coprecipitated due at position 776 in ataxin-1. The sequence of ataxin-1
with ataxin-1 (Figure 1A). These proteins were purified (amino acids 773-778) is similar to a consensus 14-3-3
and subjected to trypsin digestion followed by mass binding motif (Fu et al., 2000) that comprises an essential
spectrometry. A number of chaperones were detected phosphoserine residue flanked by an arginine and pro-
in the immunoprecipitates of both ataxin-1[82Q]-S776 line (Figure 1C). This motif is present in ataxin-1 homo-
and ataxin-1[82Q]-A776, including inducible Hsp70, logs of different species, suggesting that the ataxin-1/
Hsc70, Hsp40, and BiP/GRP78 (Figure 1A, and data not 14-3-3 interaction has been evolutionarily conserved.
shown), which suggests that both forms of ataxin-1[82Q] To probe whether the ataxin-1/14-3-3 interaction is
adopt misfolded conformations readily recognized by direct or indirect, we performed a yeast two-hybrid
heat shock proteins. -actin and vimentin were also screen using an evolutionarily conserved C-terminal
detected in the immunoprecipitates of both ataxin-1 fragment of ataxin-1 (amino acids 529–816, denoted
“ataxin-1C288”, which contains the postulated 14-3-3variants. Interestingly, two proteins with apparent mo-
14-3-3 Promotes Ataxin-1-Induced Neurodegeneration
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Figure 2. 14-3-3 Interacts Directly with Ataxin-1 and Binds Most Strongly to the Expanded Form
(A and B) Ataxin-1[82Q]-S776, but not ataxin-1[82Q]-A776 interacts with 14-3-3 (A) in a yeast two-hybrid system. Double transformants of
ataxin-1[82Q]-S776/14-3-3 grew faster than those of either ataxin-1[2Q]-S776/14-3-3 or ataxin-1[30Q]-S776/14-3-3 on -Trp/-Leu/-His/-Ade
medium but grew similarly on –Trp/-Leu medium (B). BD and AD are DNA binding and activation domains, respectively.
(C) 14-3-3 binds most strongly to expanded ataxin-1. Lysates of COS1 cells transfected with FLAG-tagged ataxin-1 (2Q, 30Q, or 82Q) or a
control plasmid (mock) were immunoprecipitated with anti-FLAG. The input and immunoprecipitates were resolved in SDS-PAGE, and immu-
noblotted with anti-FLAG, anti-ataxin-1-pS776, or mixtures of anti-14-3-3 and anti-14-3-3 antibodies. Anti-14-3-3 antibodies give weaker
signals than anti-14-3-3 due to a lower affinity. 14-3-3 associates most strongly with ataxin-1[82Q] based on the amount immunoprecipitated
relative the total amount of soluble ataxin-1 that can be immunoprecipitated. Ataxin-1 variants were phosphorylated similarly as revealed by
the relative signal ratio of S776-phosphorylated ataxin-1 (p-ataxin-1) to total ataxin-1. Normalized quantification is shown.
binding motif). 14-3-3 ( and ) was the most frequently proteins in yeast, the polyglutamine tract itself is not
required for ataxin-1/14-3-3 interactions. Nonetheless,identified interactor (data not shown). When we exam-
ined the ability of full-length ataxin-1 to interact with 14- double transformants of expanded ataxin-1[82Q] and
14-3-3 grew slightly faster than those of unexpanded3-3 in the yeast two-hybrid system, we found that only
ataxin-1[82Q]-S776 (but not A776) interacted with the , ataxin-1 (2Q or 30Q) and 14-3-3 on medium lacking leu-
cine, tryptophan, histidine, and adenine (Figure 2B). This, and  isoforms of 14-3-3 (Figure 2A, and data not
shown). observation suggests that 14-3-3 binds more strongly
to mutant ataxin-1. To test the effect of polyglutamineTo determine whether ataxin-1 interacts with different
isoforms of 14-3-3 in vivo, we used isoform-specific tract length on ataxin-1/14-3-3 binding, we transfected
COS1 cells with constructs encoding ataxin-1 bearingantibodies to detect 14-3-3 proteins in ataxin-1 immuno-
precipitates from Neuro2A cells transfected with ataxin- either 2Q, 30Q, or 82Q. Although the amounts of immu-
noprecipitated ataxin-1 decreased with longer gluta-1[82Q]-S776. Several 14-3-3 isoforms, including , , ,
, and , were detectable in the immunocomplex of mine tracts because of lower protein solubility, similar
amounts of 14-3-3 coimmunoprecipitated with eachataxin-1 (data not shown).
protein (Figure 2C); i.e., the relative amount of immuno-
precipitated 14-3-3 was highest in cells transfected with14-3-3 Associates Most Strongly
with Expanded Ataxin-1 ataxin-1[82Q]. These differences could not be attributed
to changes in the endogenous levels of 14-3-3 proteins,Because the ataxin-1C288 fragment that does not con-
tain the polyglutamine tract can interact with 14-3-3 which did not differ in the transfected cells (Figure 2C,
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input). Because 14-3-3 binding is usually phosphoryla- we transfected HeLa cells with 14-3-3 and ataxin-1. As
predicted, 14-3-3 overexpression greatly increased thetion-dependent, we speculated that ataxin-1 with poly-
glutamine tracts of variable lengths might be phosphory- steady-state levels of ataxin-1[82Q]-S776, but not
ataxin-1[82Q]-A776 (Figure 3C); this effect was muchlated differentially. We tested this hypothesis using an
antibody, PN1168, that specifically recognizes ataxin-1 more pronounced with expanded ataxin-1[82Q]-S776
than with ataxin-1[2Q]-S776. This result is consistentwith a phosphoserine at position S776 (Emamian et al.,
2003; denoted as anti-ataxin-1-pS776). Immunoblotting with our finding that ataxin-1[82Q] has a higher binding
affinity to 14-3-3 (Figures 2B and 2C). More importantly,with this antibody showed that ataxin-1 proteins were
phosphorylated similarly irrespective of polyglutamine we found that 14-3-3 must interact directly with ataxin-1
to stabilize it. Ataxin-1[82Q]-A776, which is defectivetract length (Figure 2C). Therefore, the differential abili-
ties of ataxin-1 2Q, 30Q, and 82Q to interact with 14- in the 14-3-3 binding, resisted stabilization by 14-3-3
(Figure 3C). The differential effects of 14-3-3 on ataxin-13-3 are not attributable to different levels of phosphory-
lation. Rather, it is likely that expanded ataxin-1[82Q] variants ruled out the possibility that 14-3-3 might gener-
ally enhance the transcription of the transgenes, sinceattains a certain conformation that is more favorable for
14-3-3 binding. all of them are driven by the same promoter. These data
suggest that 14-3-3 modulates mutant ataxin-1 toxicity
by retarding ataxin-1 degradation.14-3-3 Stimulates Ataxin-1 Inclusion Formation
We examined the subcellular localization of ataxin-1 and
14-3-3 in COS1 cells. In cells transfected with 14-3-3 14-3-3 Aggravates Neurodegeneration
in SCA1 Fliesalone, 14-3-3 distributed to both the cytoplasm and nu-
cleoplasm (Figure 3A, arrowhead), as observed pre- To investigate the in vivo effects of 14-3-3 on ataxin-1-
induced neurodegeneration in our fly model of SCA1viously (Brunet et al., 2002). In cells transfected with both
proteins, 14-3-3 was recruited to the nuclear aggregates (Fernandez-Funez et al., 2000), we generated double
transgenic flies expressing ataxin-1[82Q] and Drosoph-formed by ataxin-1 (Figure 3A, arrows). Could 14-3-3
influence ataxin-1’s ability to form inclusions or become ila 14-3-3 (d14-3-3) using the GAL4/UAS system, in
which transgenic expression is directed to the retina bysequestered itself in aggregates and thus be diverted
from its normal functions? To answer these questions the gmr-GAL4 driver (see Fernandez-Funez et al., 2000).
To increase our chances of observing subtle pheno-we sought to determine whether 14-3-3 modulates
ataxin-1’s ability to form inclusions or if 14-3-3 overex- types, we raised transgenic flies at 23C to allow a lower
level of ataxin-1[82Q] expression (Fernandez-Funez etpression influences ataxin-1-induced neurodegener-
ation. al., 2000). Under this condition, transgenic flies express-
ing ataxin-1[82Q] alone (SCA182Q) displayed a mild de-A majority of COS1 cells (over 70%) transiently trans-
fected with ataxin-1[82Q]-S776 develop numerous nu- generative phenotype with a moderate disruption of the
regular external lattice, a thinner retina layer, and mildlyclear inclusions (Cummings et al., 1998), whereas cells
transfected with ataxin-1[82Q]-A776, which is defective abnormal rhabdomeres (Figure 4A, panels 2 and 5, and
data not shown). Overexpression of d14-3-3 in fliesin 14-3-3 binding, show ataxin-1[82Q]-A776 distributed
throughout the nucleoplasm, with fewer than 10% of produces no deleterious effects on its own (data not
shown). But SCA182Q/d14-3-3 double transgenic fliestransfectants forming inclusions (Emamian et al., 2003).
We tested the effects of different levels of 14-3-3 on had a much more severe phenotype than those express-
ing ataxin-1[82Q] alone, showing profoundly disorderedataxin-1 inclusion formation. To achieve a condition of
14-3-3 overexpression, we cotransfected COS1 cells ommatidia, a thin and disorganized retina layer, and
grossly abnormal rhabdomeres (Figure 4A, panels 3 andwith 14-3-3 and ataxin-1 at a higher molar ratio (5:1, 14-
3-3 to ataxin-1) than the 1:1 ratio used earlier (cf., Figure 6, and data not shown). This aggravated phenotype was
observed in SCA182Q/d14-3-3 double transgenic flies3A). 14-3-3 overexpression had little effect on ataxin-
1[82Q]-A776, which remained evenly distributed in the derived from different individual weak lines for both
transgenes (data not shown). 14-3-3 thus intensifiesnucleoplasm of most transfectants (Figure 3B, panels 4
to 6). Rare ataxin-1[82Q]-A776 aggregates were de- ataxin-1-induced neurodegeneration in a fly model of
SCA1.tected in some transfectants, but in these cells, 14-3-3
was evenly distributed and did not redistribute to the site
of the inclusions (Figure 3B, panels 4 to 6, arrowhead). 14-3-3 Stabilizes Ataxin-1 in SCA1 Flies
Transfectants expressing high levels of 14-3-3 along Upon breeding different d14-3-3 transgenic lines to
with ataxin-1[82Q]-S776, however, bore numerous large SCA182Q flies, a synthetic lethality in the double trans-
inclusions (Figure 3B, panels 1 to 3, arrows). These inclu- genic animals was reproducibly observed in combina-
sions frequently occupied more than half of the nuclear tions of lines that have relatively high expression of
volume and expelled chromatin to the edge of nuclei— either d14-3-3 or SCA182Q transgenes (data not shown).
such aggravated inclusion formation is never seen when While all high-expressing transgenic animals bearing
ataxin-1[82Q]-S776 is transfected alone (data not only the SCA182Q or the d14-3-3 transgene develop nor-
shown; Cummings et al., 1998). mally to adulthood, double transgenic animals died in
the second to third instar larval stage. This effect is
specific to ataxin-1, as we have not observed lethality in14-3-3 Increases Steady-State Levels of Ataxin-1
We hypothesized that the ability of 14-3-3 to stimulate flies overexpressing d14-3-3 in conjunction with other
transgenes (data not shown). This result demonstratesataxin-1 inclusion formation resulted from its ability to
stabilize the mutant protein. To test this hypothesis, a specific interaction between ataxin-1 and d14-3-3:
14-3-3 Promotes Ataxin-1-Induced Neurodegeneration
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Figure 3. 14-3-3 Stabilizes Ataxin-1 through Their Interactions
(A) COS1 cells were transfected with GFP-ataxin-1[82Q]-S776 and pIRES-HA-14-3-3/myc-14-3-3(left and middle panels, respectively).
Confocal microscopy analysis revealed that ataxin-1[82Q]-S776 (GFP, green) and 14-3-3 (anti-HA, red) extensively colocalize (yellow) in
double transfectants (arrows in the merged image, right panel). In cells transfected with 14-3-3 alone (arrowhead), 14-3-3 was distributed to
the cytoplasm and nucleoplasm. (B) COS1 cells were cotransfected with FLAG- ataxin-1[82Q] (S776; panels 1 to 3 or A776; panels 4 to 6)
and myc14-3-3. Double immunofluorescence staining was done using anti-FLAG (green) and anti-myc (red) antibodies, whereas the DNA
was counterstained with DAPI (Blue). Huge ataxin-1 inclusions (arrows) form when 14-3-3 is overexpressed with ataxin-1[82Q]-S776. In
contrast, ataxin-1[82Q]-A776 was evenly distributed in most cells irrespective of the coexpression of 14-3-3. Nuclear inclusions formed by
ataxin-1[82Q]-A776 were present in only a few cells (arrowhead).
(C)14-3-3 overexpression increases steady-state levels of ataxin-1 harboring S776 but not A776. HeLa cells were cotransfected with FLAG-
ataxin-1 ([2Q]-S776, [82Q]-S776, or [82Q]-A776) and myc-tagged 14-3-3 (), or a control plasmid (	). Immunoblotting was done with anti-
FLAG, anti-ataxin-1-pS776, and mixtures of anti-GAPDH and anti-myc antibodies.
ataxin-1 toxicity was greatly enhanced in animals car- UAS promoter might give rise to low expression of
ataxin-1 that gradually accumulates in the presence ofrying overexpression alleles of d14-3-3.
Oddly, this early lethality of SCA182Q/d14-3-3 double leaky d14-3-3 expression due to the latter’s stabiliza-
tion effect upon ataxin-1. We therefore examined thetransgenic animals occurred even in the absence of
gmr-GAL4 driver. We speculated that the leakage-prone larvae of SCA182Q/d14-3-3 double transgenic animals
Cell
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Figure 4. 14-3-3 Stabilizes Mutant Ataxin-1
and Enhances Its Toxicity in Flies
(A) 14-3-3 promotes ataxin-1-induced neuro-
degeneration. SEM eye images (panels 1–3)
and vertical eye sections (panels 4–6) of a
control fly eye (gmr-GAL4/, panels 1 and
4), or transgenic fly eyes expressing mutant
ataxin-1 (UAS-SCA182Q[F7]/gmr-GAL4, pan-
els 2 and 5), or ataxin-1 with Drosophila 14-
3-3 (UAS-SCA182Q[F7]/gmr-GAL4/UAS-d14-
3-3[9or], panels 3 and 6). Insets in panels 1–3
are higher magnification views of ommatidia.
Arrows indicate retinal thickness (panels 4–6).
Ataxin-1/14-3-3 double transgenic flies
(panels 3 and 6) show severe disruption of
external lattice and a thin, disorganized ret-
ina. Flies were raised at 23C. Scale bar: 100

m (panel 1), 50 
m (panel 4).
(B) Leaky levels of mutant ataxin-1 are dra-
matically increased in SCA182Q/d14-3-3 dou-
ble transgenic animals in the absence of a
GAL4 driver. Leaky ataxin-1[82Q] expression
was barely detectable in the second instar
larvae of animals carrying SCA182Q transgene
alone (UAS-SCA182Q[N35y]/TM3, panel 1) but
was high in in the mandibles (mand) and sali-
vary glands (SG) of SCA182Q/d14-3-3 animals
(UAS-SCA182Q[N35y]/UAS-d14-3-3, panel 2)
due to its stabilization. Ataxin-1[82Q] was
also detectable in a few brain neurons (Br).
Insets show higher magnifications of the sali-
vary glands. Scale bar: 50 
m.
for leaky expression of ataxin-1 in the absence of the phorylation assay by incubating bacterially expressed
glutathione S-transferase-ataxin-1[30Q] fusion proteinGAL4 driver. We found significant amounts of ataxin-1
(GST-ataxin-1) with purified Akt1 kinase in a kinase reac-in many polytenic cells in the mandible and in the salivary
tion buffer. As determined by autoradiography for 32Pglands of SCA182Q/d14-3-3 larvae (Figure 4B, panel 2),
incorporation, GST-ataxin-1, but not a control GST pro-while ataxin-1 was barely detectable in larvae carrying
tein, was heavily phosphorylated by Akt1 kinase (Figurethe SCA182Q transgene alone (Figure 4B, panel 1). This
5A). This result suggests that ataxin-1 is indeed a sub-finding is consistent with our observation that coexpres-
strate of Akt kinase. In addition, Akt1 phosphorylatession of 14-3-3 with ataxin-1[82Q] in transfected cells
ataxin-1 at the S776 residue, since the bacterially ex-leads to the accumulation of ataxin-1[82Q] (Figure 3C).
pressed ataxin-1 was recognized by anti-ataxin-1-This result also supports the notion that ataxin-1 accu-
pS776 antibody only after Akt phosphorylation (Fig-mulation due to the stabilizing interaction with 14-3-3
ure 5A).causes the synthetic lethality in SCA182Q/d14-3-3 dou-
To determine whether ataxin-1 is phosphorylated byble transgenic animals.
Akt in vivo, we cotransfected HeLa cells with ataxin-
1[2Q] and either a constitutively active form of Akt1
Ataxin-1 Is a Substrate of Akt Kinase (CA-Akt) or an inactive dominant-negative form of Akt1
To determine if the interaction of ataxin-1 and 14-3-3 is (DN-Akt). We found that CA-Akt induced ataxin-1 phos-
regulated by protein phosphorylation at the S776 resi- phorylation while DN-Akt inhibited it (Figure 5B). Inter-
due, we sought to identify the kinase that phosphory- estingly, coexpression of CA-Akt increased the steady-
lates ataxin-1 at S776. We analyzed the sequence of state levels of ataxin-1-S776 but not ataxin-1-A776,
ataxin-1 with a motif search program at the Scansite while levels of the endogenous 14-3-3 remained un-
website (http://scansite.mit.edu; Yaffe et al., 2001) and changed (Figure 5B and data not shown).
identified the S776 residue as a putative Akt kinase
phosphorylation site. This consensus motif for Akt phos- Interaction of Ataxin-1 and 14-3-3 Requires Akt
phorylation (RXRXXS) is conserved in ataxin-1 homo- Phosphorylation at S776
logs (Figure 1C). To determine whether ataxin-1 is a The importance of Akt phosphorylation for the associa-
tion of ataxin-1 and 14-3-3 was examined using an insubstrate of Akt kinase, we performed an in vitro phos-
14-3-3 Promotes Ataxin-1-Induced Neurodegeneration
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Figure 5. Interaction of Ataxin-1 with 14-3-3 Requires Akt Phosphorylation
(A) Akt phosphorylates ataxin-1 at S776 in vitro. Assays were performed using purified Akt1 kinase and bacterial GST or GST-ataxin-1[30Q]
as substrates. Ponceau S staining (left 2 panels), and immunoblotting with anti-ataxin-1-pS776 or anti-GST antibodies (right 2 panels) are
shown.
(B) Akt phosphorylates ataxin-1 at S776 in vivo. HeLa cells were cotransfected with FLAG- ataxin-1[2Q]-S776 and either constitutively active
(CA-Akt), dominantly negative (DN-Akt) forms of Akt1, or a control plasmid (	). Immunoblotting with anti-ataxin-1-pS776, anti-FLAG, or anti-
14-3-3 antibodies revealed the S776-phosphorylated ataxin-1 (p-ataxin-1), total ataxin-1, or 14-3-3 respectively. The relative ratios of the
S776-phosphorylated ataxin-1 to total ataxin-1 are shown.
(C) Ataxin-1 binding to 14-3-3 requires Akt phosphorylation. Immunopurified 14-3-3 was incubated with either GST, unphosphorylated GST-
ataxin-1, or Akt1-phosphorylated GST-ataxin-1 (GST-p-ataxin-1). GST-fused proteins (input) and the 14-3-3-bound proteins were resolved by
SDS-PAGE and immunoblotted with anti-ataxin-1, anti-ataxin-1-pS776, or mixture of anti-14-3-3 and anti-14-3-3 antibodies.
(D) Akt phosphorylation regulates 14-3-3 binding to ataxin-1 in vivo. HeLa cells were cotransfected with FLAG-ataxin-1[2Q] and either CA-
Akt, DN-Akt, or a control plasmid (	). Lysates were immunoprecipitated with anti-FLAG antibodies. Similar amounts of ataxin-1 immunoprecipi-
tates were resolved by SDS-PAGE and immunoblotted with anti-FLAG or mixtures of anti-14-3-3 and anti-14-3-3 antibodies. Relative signal
ratios of coimmunoprecipitated 14-3-3 to ataxin-1 are shown below.
vitro binding assay. Bacterially expressed GST or GST- transfectants coexpressing ataxin-1 and DN-Akt (Figure
5D). This result suggests that ataxin-1 association withataxin-1[30Q] were purified to homogeneity and incubated
with purified 14-3-3 proteins that were immobilized on 14-3-3 is regulated by Akt kinases in vivo.
antibody-conjugated agarose. Ataxin-1 associated with
14-3-3 only when ataxin-1 was phosphorylated with Phosphatidylinositol 3-Kinase/Akt Pathway
Modulates Ataxin-1-InducedAkt1 kinase (Figure 5C). We next cotransfected HeLa
cells with ataxin-1[2Q] and either CA-Akt or DN-Akt and Neurodegeneration
Knowing that Akt kinase regulates the binding ofcarried out immunoprecipitation on lysates from these
cells to pull down ataxin-1 protein complexes. Because ataxin-1 to 14-3-3, we postulated that Akt kinase might
modulate ataxin-1-induced degeneration. To test thisataxin-1 levels varied with Akt1 coexpression (Figure
5B), the amounts of immunoprecipitates resolved in hypothesis, we crossed SCA182Q flies with flies overex-
pressing Drosophila Akt1 (dAkt1) under the control ofSDS-PAGE were adjusted according to the levels of
ataxin-1 to have a similar amount of immunoprecipitated the gmr-GAL4 driver. Flies overexpressing dAkt1 alone
exhibited slightly enlarged eyes and a mild disruptionataxin-1 in each lane (Figure 5D). Coimmunoprecipita-
tion of 14-3-3 was increased in transfectants with of the regular, external lattice, as previously described
(Verdu et al., 1999; Figure 6A, panels 1 and 2). SCA182Q/ataxin-1 and CA-Akt (Figure 5D); this could not be attrib-
uted to changes in the endogenous levels of 14-3-3 dAkt1 double transgenic flies showed profoundly disor-
ganized ommatidia and numerous necrotic spots (Figureproteins, which were similar in all cells (Figure 5B and
data not shown). On the other hand, coimmunopre- 6A, panel 6, see inset), a much more severe phenotype
than found in flies expressing dAkt1 or ataxin-1[82Q]cipitation of 14-3-3 was significantly decreased in
Cell
464
Figure 6. PI3K/Akt Signaling Modulates
Ataxin-1-Induced Neurodegeneration in Flies
(A) Akt and PI3K promote ataxin-1-induced
neurodegeneration. Shown are SEM eye im-
ages of a control fly eye (gmr-GAL4/, panel
1) or fly eyes expressing dAkt1 (UAS-dAkt1/
gmr-GAL4, panel 2), dPI3K (UAS-dPI3K/gmr-
GAL4, panel 3), dPDK1 (dPDK1EP(3)3553/gmr-
GAL4, panel 4), ataxin-1[82Q] (UAS-
SCA182Q[F7]/gmr-GAL4, panel 5) alone,
ataxin-1[82Q] together with dAkt1 (UAS-
SCA182Q[F7]/UAS-dAkt1/gmr-GAL4, panel 6),
dPI3K (UAS-SCA182Q[F7]/UAS-dPI3K/gmr-
GAL4, panel 7), or dPDK1 (UAS-SCA182Q[F7]/
dPDK1EP(3)3553/gmr-GAL4, panel 8). All flies
were raised at 23C. Scale bar: 100
m. Insets
show a higher magnification of ommatidia
field.
(B) Akt and PI3K induce ataxin-1 protein ac-
cumulation. Immunofluorescence staining of
larval eye discs from flies expressing ataxin-
1[82Q] alone (elav-GAL4 UAS-SCA182Q[F7]/,
panel 1), ataxin-1[82Q] together with dAkt1
(elav-GAL4 UAS-SCA182Q[F7]/UAS-dAkt1,
panel 2) or dPI3K (elav-GAL4 UAS-
SCA182Q[F7]/UAS-dPI3K, panel 3) with anti-
ataxin-1 antibodies (11750VII). Semi-quantifi-
cation of fluorescence signals (in arbitrary
units) from each transgenic fly is provided
in right panel (n  7). Ataxin-1 staining was
significantly stronger in flies coexpressing
dAkt or dPI3K (p  0.005).
(C) Modulation of ataxin-1 neurodegeneration
by Akt1 is dosage dependent.
Shown are SEM eye images (panels 1 and 2)
and eye sections (panels 5 and 6) of sibling
male flies expressing ataxin-1[82Q] (UAS-
SCA182Q[F7]/Tp(3;Y)L58/gmr-GAL4, panels 1
and 5), or ataxin-1[82Q] with a chromosomal
duplication of dAkt1 (UAS-SCA182Q[F7]/
Dp(3:Y)L58/gmr-GAL4, panels 2 and 6) and
raised at 23C. Transgenic flies expressing
ataxin-1[82Q] (UAS-SCA182Q[F7]/gmr-GAL4,
panels 3 and 7) or ataxin-1[82Q] and hetero-
zygous for a loss-of-function allele of dAkt1
(UAS-SCA182Q[F7]/gmr-GAL4/dAkt10422, pan-
els 4 and 8) were raised at 26.5C and their
SEM eye images (panels 3 and 4) and eye
sections (panels 7 and 8) are shown. Insets
(panels 1–4) show a higher magnification of
ommatidia field. Arrows indicate retinal thick-
ness (panels 5–8). Scale bar: 50 
m.
alone (Figure 6A, panels 2 and 5). Eye sections of these dGSK3, caused severe disorganization on their own
(Figure 6A, panels 3 and 4, and data not shown). Strik-flies revealed a severely disorganized retina with de-
formed or missing rhabdomeres (data not shown). Akt ingly, overexpression of dPI3K dramatically worsened
ataxin-1 neurodegeneration (Figure 6A, panel 7), whileoverexpression clearly exacerbates ataxin-1 toxicity.
Akt is a component of the phosphatidylinositol neither dPDK1 nor dGSK3 had a significant effect (Figure
6A, panel 8, and data not shown). Ataxin-1 levels were3-kinase (PI3K)/Akt signaling pathway (Cantley, 2002).
To investigate the possible role of PI3K/Akt signaling in significantly increased by coexpression of dAkt1 or
dPI3K as detected by immunofluorescence staining ofSCA1 pathogenesis, we crossed the SCA182Q flies with
flies overexpressing either Drosophila PI3K (dPI3K) or larval eye discs (Figure 6B). This observation is consis-
tent with our findings that Akt induced ataxin-1 accumu-phosphoinositide-dependent kinase-1 (dPDK1), two
signaling components upstream of Akt known to regu- lation in transfected cells by enhancing the binding of
ataxin-1 to 14-3-3 (Figures 5B and 5D). Interestingly,late cell size in Drosophila. We also evaluated the effect
of glycogen synthase kinase 3 (dGSK3), a downstream ataxin-1 levels are significantly higher in flies coexpress-
ing dPI3K than in those coexpressing dAkt1 (p 0.05),effector of Akt. All these transgenes were expressed
under the control of the gmr-GAL4 driver. Similar to correlating with the more pronounced degeneration
caused by dPI3K (Figure 6B and Figure 6A, panel 7dAkt1, overexpression of dPI3K and dPDK1 increased
the ommatidia and eye size, but none of them, including compared with panel 6). These data demonstrate that
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PI3K/Akt signaling leads to mutant ataxin-1 accumula- nism by which 14-3-3 renders ataxin-1 more toxic to
neurons.tion and augments ataxin-1-induced neurodegener-
ation. Previous studies have revealed that 14-3-3 can pro-
tect its target protein from proteolysis and dephosphor-To further investigate the role of Akt in modulating
the SCA1 phenotype, we crossed SCA182Q flies with flies ylation (Tzivion and Avruch, 2002). For example, 14-3-3
stabilizes the nicotinic receptor 4 subunit, elevating itsbearing either a chromosomal duplication of dAkt1 or a
loss-of-function allele of dAkt1 (neither of which caused steady-state protein levels (Jeanclos et al., 2001). In this
study, we found that 14-3-3 binds and stabilizes ataxin-1degeneration on their own [data not shown]). SCA182Q
flies bearing 3 copies of dAkt1 displayed an exacerbated and promotes its accumulation in both transfected cells
and transgenic flies. The ataxin-1/14-3-3 interaction mightdegenerative phenotype (Figure 6C, panels 2 and 6 com-
pared with panels 1 and 5). The effect of dAkt1 loss-of- directly stabilize a conformation of ataxin-1 that resists
degradation or it might impede access to other ataxin-1-function was evaluated in SCA182Q flies raised at a higher
temperature (26.5C) (at which ataxin-1[82Q] itself in- interacting proteins that would facilitate protein clear-
ance. Note that 14-3-3 interacts not only with the expandedduces a more severe degenerative phenotype [Figure
6C, panels 3 and 7]). Under this condition, ataxin-1- mutant ataxin-1 but also the unexpanded wild-type pro-
tein. It is therefore possible that 14-3-3 regulatesinduced neurodegeneration was less severe in SCA182Q
flies heterozygous for a loss-of-function allele of dAkt1 ataxin-1’s clearance under physiological conditions.
This regulation becomes problematic upon CAG repeat(Figure 6C, panels 4 and 8). Stronger suppression of the
SCA1 phenotype was observed in flies homozygous for expansion, since longer polyglutamine tracts enhance
ataxin-1’s interaction with 14-3-3, further stabilizing thea hypomorphic loss-of-function dAkt1 allele, although
those flies were also smaller due to dAkt1 loss-of-func- mutant protein.
tion (Supplemental Figure S1 available at http://www.
cell.com/cgi/content/full/113/4/457/DC1). These results 14-3-3 in SCA1 Pathogenesis
demonstrate that dAkt1 modulates the ataxin-1-induced We found that 14-3-3 promoted the accumulation of
neurodegeneration in a dosage-dependent manner. The ataxin-1 and also enhanced aggregate formation. The
suppression of the SCA1 phenotype by dAkt1 loss-of- finding that 14-3-3 aggravates SCA1 pathogenesis to-
function is particularly important in that it allows us to gether with data by Emamian et al. (2003) showing the
rule out potential effects caused by protein overexpres- absence of nuclear inclusions and neuronal dysfuction
sion. Moreover, it raises the possibility that reducing the in mice overexpressing ataxin-1[82Q]-A776 might resur-
activity of Akt kinases might suppress SCA1 pathology rect the old question of whether nuclear inclusions
and hold therapeutic value. cause SCA1 pathogenesis, but when ataxin-1 is ex-
pressed at physiologic levels, under control of endoge-
nous promoter, neuronal dysfunction occurs in the ab-Discussion
sence of visible nuclear inclusions (Watase et al., 2002).
The absence of nuclear inclusions in ataxin-1[82Q]-A776Although polyglutamine expansion is itself pathogenic,
mice most likely resulted from efficient clearance of thethe toxicity of mutant ataxin-1 is modulated by several
mutant protein due to its lack of interaction with 14-3-3.cis-/trans-acting factors. Components of the protein
To investigate the possibility that sequestration of 14-folding and ubiquitin-proteasome pathways, such as
3-3 with mutant ataxin-1 interferes with the cellular func-chaperones and Ube3a ligase, are trans-acting modula-
tions of 14-3-3, we evaluated the effects of 14-3-3 over-tors for ataxin-1’s toxicity in cells, flies, and mice (reviewed
expression on the SCA1 phenotype in vivo and foundin Zoghbi and Botas, 2002). A recently discovered cis-
no evidence that loss of 14-3-3 cellular functions playsacting factor is serine 776, which is phosphorylated in
a major role in SCA1 pathogenesis. If SCA1 pathologyvivo (Emamian et al., 2003). An S776A mutation abol-
was caused simply by sequestration of 14-3-3 byished the ability of ataxin-1[82Q] to induce neurodegen-
ataxin-1, one would expect exogenous 14-3-3 to sup-eration in transgenic mice even when ataxin-1 harbored
press the phenotype—yet overexpression of 14-3-3 inan expanded polyglutamine tract and was localized to
SCA1 flies aggravated degeneration. In fact, immuno-the nucleus (Emamian et al., 2003). This finding under-
labeling of cerebellar sections from transgenic mice ov-scored the role of S776 in SCA1 pathogenesis. In this
erexpressing ataxin-1[82Q]-S776 revealed that the dis-study, we probed the mechanism by which the S776
tribution of 14-3-3 remains grossly unchanged withoutresidue confers toxicity onto ataxin-1[82Q]. We found
sequestration into nuclear inclusions (data not shown);that, upon Akt-dependent phosphorylation, S776 medi-
the colocalization of the two proteins to inclusions inates the interaction of ataxin-1 with 14-3-3.
cell cultures could be modulated by differences in other
cellular proteins or the nature of inclusions (formed over
hours in cells versus days and weeks in mice). It is14-3-3 Modulates SCA1 Pathogenesis by
Stabilizing Ataxin-1 likely that 14-3-3 and ataxin-1 preferentially form soluble
protein complexes in vivo, whereby only a minor fraction14-3-3 proteins bind to phosphopeptide motifs in a vari-
ety of cellular proteins to regulate diverse biological of 14-3-3 is present in nuclear aggregates.
Consistent with the notion that polyglutamine expan-processes such as signal transduction, cell cycle con-
trol, and apoptosis (Fu et al., 2000). The function of sion confers some toxic gain-of-function onto the host
protein (Zoghbi and Orr, 2000), we found that larger14-3-3 binding to ataxin-1 remains unclear, since the
cellular function of ataxin-1 is not well understood. The polyglutamine expansions in ataxin-1 have a higher af-
finity for 14-3-3. 14-3-3 is able to stabilize wild-typepresent study does, however, shed light on the mecha-
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late -synuclein (Kawamoto et al., 2002). Interestingly,
-synuclein shares sequence homology with 14-3-3 and
binds both to 14-3-3 and to some 14-3-3 binding part-
ners (Ostrerova et al., 1999). This finding suggests a
possible role for either 14-3-3 or 14-3-3 binding proteins
in -synuclein-induced pathology. Moreover, 14-3-3
was recently found to associate with -synuclein in a
soluble protein complex that mediates dopamine-
dependent neurotoxicity (Xu et al., 2002). It would be
interesting to determine whether 14-3-3 plays any role
in stabilizing -synuclein. When searching for consen-
sus 14-3-3 binding motifs in other polyglutamine-con-
taining proteins, we found the RXXSXP motif in ataxin-2,
1A subunit voltage-gated calcium channel, ataxin-7,
and atrophin-1. Further studies are necessary to deter-
mine if there is an interaction between these proteins
and 14-3-3 and whether such interactions affect the
pathogenesis of SCA2, SCA6, SCA7, and DRPLA, re-
spectively.
PI3K/Akt Signaling and Neurodegeneration
Akt phosphorylates ataxin-1 and promotes its binding
to 14-3-3, which in turn leads to ataxin-1 accumulation
and neurodegeneration (Figure 7). Loss of dAkt1 func-
tion suppressed ataxin-1-induced neurodegeneration in
a dosage-dependent manner. Akt is activated when re-
cruited to the plasma membrane and phosphorylated
at T308 and S473 by PDK1 and a yet-to-be identified
“S473-kinase” (Brazil et al. 2002). That dPI3K overex-
pression aggravates the SCA1 phenotype more than
dAkt1 overexpression is consistent with the important
role of dPI3K in fully activating the signaling cascadeFigure 7. Model Depicting a Mechanism Contributing to Ataxin-1-
Induced Neurodegeneration (Figures 6A and 6B). Because dPDK1 overexpresssion is
insufficient to promote ataxin-1-induced degeneration,Akt phosphorylation of ataxin-1 at S776 allows 14-3-3 binding, which
stabilizes ataxin-1 perhaps by competing with factors mediating its we propose that the “S473-kinase” plays a pivotal role
degradation. The 14-3-3-bound mutant ataxin-1 gradually accumu- in activating dAkt to modulate ataxin-1’s toxicity.
lates and causes neurodegeneration. PI3K/Akt signaling is a major pathway mediating sur-
vival signals in neuronal cells in response to factors such
as insulin-like growth factor 1 (IGF-1; Brunet et al., 2001;
ataxin-1, however, and overexpression of 14-3-3 in Cantley, 2002, Hunter, 2000). Therefore, PI3K/Akt signal-
SCA130Q flies enhanced the neurotoxicity of ataxin- ing is generally considered neuroprotective, acting
1[30Q] (data not shown). These observations are consis- against stress conditions that occur during neurodegen-
tent with the proposed role for 14-3-3 in stabilizing eration. IGF-1 is known to activate PI3K/Akt signaling
ataxin-1 (Figure 7). The neurotoxic effects of mutant and to protect against neuronal death induced by amy-
ataxin-1 are likely to be more pronounced in cells ex- loid- peptide, a toxic agent in AD (Dore et al., 1997;
pressing high levels of 14-3-3. Many of the 14-3-3 iso- Wei et al., 2002). Likewise, Akt activation triggered by
forms are abundantly expressed in brain tissue, with IGF-1 inhibits neuronal death induced by mutant hunt-
different expression patterns for each cell-type; iso- ingtin (Humbert et al., 2002).
forms , , and  are particularly abundant in Purkinje It is therefore surprising to find that in SCA1 flies, PI3K/
cells (Baxter et al., 2002), which suffer the most severe Akt promoted ataxin-1-induced neurodegeneration. It
degeneration. High expression levels of certain 14-3-3 is possible that PI3K and Akt triggered survival signaling,
isoforms could contribute to the selective neuronal vul- as they do in other conditions, but also induced ataxin-1
nerability characteristic of SCA1. phosphorylation and thus its interaction with 14-3-3.
Whatever survival-promoting effect they exert may be
counteracted by the greater neurotoxicity of mutant14-3-3 and Human Neurodegenerative Disorders
Previous studies have found links between 14-3-3 and ataxin-1 accumulation in the cells. It is unlikely that Akt
phosphorylation of ataxin-1 was programmed solely asother human neurodegenerative disorders. The neurofi-
brillary tangles in AD are composed primarily of hyper- a self-destruction pathway to antagonize cell survival
signaling; it is more likely that the physiological activityphosphorylated tau proteins (Lee et al., 2001) and con-
tain 14-3-3 (Layfield et al., 1996), which modulates tau of ataxin-1 is regulated in accordance with cell survival
signaling. The differential effects of PI3K/Akt signalingphosphorylation (Hashiguchi et al., 2000). Whether this
interaction stabilizes tau remains to be determined. In upon each pathogenic protein exemplify the diversity of
cellular responses in different human neurodegenerativePD, 14-3-3 is detectable in Lewy bodies, which accumu-
14-3-3 Promotes Ataxin-1-Induced Neurodegeneration
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Yeast Two-Hybrid Screeningdiseases. Activation of PI3K/Akt might have beneficial
A C-terminal fragment (amino acids 529–816) was PCR amplifiedeffects for some neurodegenerative diseases but be del-
(see Supplemental Table S1 at above URL for primer sequences)eterious for others. The availability of fly and mouse
to generate pGBKT7-ataxin-1C288. Yeast transformants (strain
models for various neurodegenerative disorders will AH109) of pGBKT7-ataxin-1C288 were transformed with plasmids
allow in vivo analysis of PI3K/Akt signaling as well as 14- from human brain and spleen cDNA libraries (Clontech). Approxi-
mately 1  106 transformants were screened for growth on medium3-3 interactions in various neurodegenerative disorders.
lacking leucine, tryptophan, histidine, and adenine. Among 126 posi-Because 14-3-3 proteins are functionally interchange-
tive clones, 14-3-3 was identified 6 times, and once for 14-3-3.able in different species (Irie et al., 1994), data obtained
Human 14-3-3 and 14-3-3 cDNAs were inserted in pACT2 (Clon-in model organisms are likely to prove clinically relevant.
tech) and were transformed to AH109 yeasts with pGBKT7-ataxin-1
In sum, we have found a mechanism by which PI3K/ ([2Q]-S776, [30Q]-S776, [82Q]-S776, or [82Q]-A776) to test for inter-
Akt signaling and 14-3-3 modulate ataxin-1 neurotoxic- actions.
ity. The identification of factors modulating SCA1 pathol-
ogy may lead to therapeutic interventions such as in-
Histology, Immunofluorescence Microscopy,terfering with ataxin-1/14-3-3 interaction using small
and Confocal Microscopy
peptides or reducing PI3K/Akt signaling by specific ki- Eye sections, histological and indirect immunofluorescence stain-
nase inhibitors. ings were performed as described (Fernandez-Funez et al. 2000).
Confocal microscopy was performed using a Zessis LSM 510 micro-
scope. For double labeling, images from the same confocal plane
Experimental Procedures were recorded. Immunofluorescence staining of larval tissues was
done with anti-ataxin-1 antibody (11750VII). Ataxin-1 fluorescent
Mammalian Expression Constructs signals of eye discs were recorded in Z-stacks of 1 
m thickness by
Plasmids for FLAG-tagged ataxin-1 variants and GFP-ataxin-1 have Biorad confocal microscope using the same settings. The Z-stacks
been described (Cummings et al., 1998; Emamian et al., 2003). 14-3- were flattened and signal was quantified using ImageJ software.
3 and 14-3-3 cDNAs were C-terminally tagged with haemagglutinin Average signal from seven samples for every genotype was calcu-
(HA)- and myc-epitopes respectively by PCR (Primer sequences lated and plotted using Excel software.
shown in Supplemental Table S1 available online at http://cgi/
content/full/113/4/457/DC1). The products were inserted into
pIRES2 (Clontech) to make a bi-cistronical expression plasmid Drosophila Genetics
pIRES-HA-14-3-3 /myc-14-3-3. Myc-14-3-3 was subcloned into Drosophila 14-3-3 was inserted in the pUAST vector for generating
pcDNA3.1 (Invitrogen). pUSEamp-Akt1 (N-terminal myristoylation) one UAS-d14-3-3 transgenic line. Thirty-two new UAS-d14-3-3
and pUSEamp-Akt1 K179M (Upstate) expressed constitutively ac- lines were generated by mobilization of the original line with transpo-
tive and dominant negative-Akt1. sase and then crossed with the weak line SCA182Q[F7]/gmr-GAL4 at
23C. The d14-3-3 transgenic lines were classified (weak/strong)
based on their ability to produce synthetic lethality over SCA182Q.
Immunoprecipitation, Mass Spectrometry, The null allele 14-3-3 ex4 was generated by imprecise mobilization
and Western Blotting Analysis of the P element insertion 14-3-3j2B10. Females of the strong y w
Cell transfections were done by Lipofectamine 2000 (Invitrogen). UAS-SCA182Q[N35y] line crossed with males y w; UAS-d14-3-3/
Whole cell extacts were prepared in RIPA buffer (50 mM Tris-HCl TM3,Sb produced slow moving, necrotic larvae y w UAS-
[pH 8.0], 0.15 M NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxy- SCA182Q[N35y]/UAS-d14-3-3 and normal siblings y w UAS-
cholate, and 5 mM EDTA) supplemented with protease inhibitor SCA182Q[N35y]/TM3,Sb that were dissected and fixed for ataxin-1
cocktail (Sigma) and phosphatase inhibitors (10 mM sodium fluoride detection. Flies of the genotypes Tp(3;Y)L58, leo07103, dAkt104226
and 5 mM sodium orthovanadate). Cells were lysed in TST buffer (Bloomington Stock Center), UAS-dAkt1 (Verdu et al., 1999),
(50 mM Tris-HCl [pH 7.5], 0.15 M NaCl, and 0.5% Triton X-100) dPDK1EP(3)3553 (Cho et al., 2001), UAS-dPI3K (Leevers et al., 1996,
containing protease inhibitors and subjected to immunoprecipita- Ludwig Institute for Cancer Research), y w; UAS-d14-3-3, y w; UAS-
tion with either anti-FLAG or anti-HA-conjugated gels (Sigma). The d14-3-3(9 or) or 14-3-3 ex4 were crossed with y w UAS-SCA182Q[F7];
Protein Chemistry Laboratory at Baylor College of Medicine per- gmr-GAL4 (Fernandez-Funez et al., 2000), or gmr-GAL4 alone as
formed mass spectrometry. Polyclonal antibodies against 14-3-3 control for adult eye analysis, or elav-GAL4 UAS-SCA182Q[F7] for
and 14-3-3 (Santa Cruz), and against , , , , and  isoforms ataxin-1 quantification in larval eye disc. All crosses incubated at
(Baxter et al., 2002) were used. Anti-ataxin-1 antibodies (11750VII) 23C, except crosses with dAkt104226 (26.5 and 27C) and 14-3-3ex4
and those against S776-phosphorylated ataxin-1 (PN1168) have and leo07103 (27.5C). Adult flies were dehydrated in 100% ethanol
been described (Emamian et al., 2003). Other antibodies used: and prepared for scanning electron microscopic (SEM) analysis of
mouse monoclonal anti-HA (BabCo), anti-myc and anti-FLAG the eyes.
(Sigma), anti-GAPDH (Advance immunochemical), rabbit polyclonal
anti-FLAG (Sigma), and goat polyclonal anti-GST (Amersham).
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